Test Price
2,800 AED✅ Home Collection Available
RBBP8 Gene Seckel Syndrome Type 2 Genetic Test in UAE | 2800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The RBBP8 Gene Seckel Syndrome Type 2 Genetic Test is a next-generation sequencing (NGS) assay that detects pathogenic variants in the RBBP8 gene associated with Seckel syndrome type 2, a rare autosomal recessive disorder characterized by severe intrauterine growth retardation, microcephaly, and distinctive facial dysmorphisms. This test enables precise molecular diagnosis, guiding clinical management and genetic counseling for affected families in the UAE. Tested using advanced NGS technology covering full coding regions, it delivers definitive results within 3–4 weeks from a simple blood, FTA card sample, or isolated DNA.
| Feature | Our Test (Precision) | Closest Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) Full Gene Sequencing | Sanger Sequencing of Single Exons |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Coverage | All coding exons ± splice sites | Targeted known mutations only |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics specialist, I understand that a genetic diagnosis like Seckel syndrome can be emotionally overwhelming for families. This test provides the molecular clarity needed to plan precise medical follow-up, including growth hormone considerations and neurosensory monitoring. All genetic results must be correlated with clinical findings and interpreted within a multidisciplinary framework." – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID 9294403
Exclusion Criteria & Red Flags
- Patients with poor venous access who cannot provide a blood sample or a single drop on FTA card; alternative buccal swab is not accepted.
- Test not indicated for acute emergency diagnostics; results are not available within the critical window for immediate life-saving decisions.
- If patient presents with seizures, respiratory distress, or signs of hypoglycemia, seek emergency care before genetic testing.
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor.
Patient FAQ & Clinical Guidance
1. What is the purpose of the RBBP8 Gene Seckel Syndrome Type 2 NGS Test?
This test analyzes the RBBP8 gene by next-generation sequencing to identify disease-causing mutations responsible for Seckel syndrome type 2, enabling accurate diagnosis, prognosis, and family risk assessment.
2. How is the sample collected and what are the requirements?
A minimally invasive whole blood sample is drawn via venipuncture, or a single drop of blood can be dried on an FTA card; DNA extraction from previously isolated DNA is also accepted. A mandatory genetic counseling session is required prior to testing.
3. What turnaround time and cost should I expect?
Standard reporting time is 3 to 4 weeks from sample receipt, with a total cost of 2800 AED, inclusive of genetic counseling report interpretation support.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and adheres to all UAE federal health data protection laws. Patient data is securely handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow the standards set by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | RBBP8 Gene Seckel Syndrome Type 2 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, FTA Card, Isolated DNA |
| Methodology Used | Next-Generation Sequencing (NGS) Full Gene Sequencing |
| ICD-10-CM Code | Q87.1, Q87.8 |
| LOINC Code | 86483-7 |
| DHA Facility License & Lab Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians